LIQVD Asia Singapore has won the digital media mandate for Glanbia Group in a multi-agency pitch. LIQVD Asia will be re-launching their digital marketing initiatives for their sports supplement ‘ON’ and ‘BSN’ in India starting this quarter. The campaign for the nutritional supplement ‘ON’ and ‘BSN’ will start from India and will be gradually penetrating into the markets of Singapore, South Korea and other Asian countries.
Glanbia plc is a cheese group and provides global nutritional solutions with leading market positions in cheese, whey proteins, sports nutrition and micronutrient premixes. It has developed a global leadership position in specialist nutritional with both a business-to-business and business-to-consumer focus.
Commenting on the newly signed partners, Sanyal, Country Head – Glanbia India said, “Innovation is an attribute that echoes in every team member of the agency for relevant and worthy solutions. We are happy to have found concurrence in our thought process with Team LA.”
Commenting on why the company chose LIQVD Asia, Clarissa Then, South Asia Marketing Manager, Glanbia Performance Nutrition said, “LA fits our requirement of a digital strategy partner as they have shown potential to be symmetrical with the core views and ideas of ‘ON’ and ‘BSN’. LA’s fresh approach towards digital singled them out as the new age partner for a brand like ours that wants to reach out to urban Asian audience.”
“We are overwhelmed and excited to work with Glanbia. The team will work with 100 per cent commitment to live up to the confidence that the brand has showed in us. We would like to deliver innovative ideas ensuring maximum reach and value for the Glanbia products through our ‘Digital. On Road’ strategies,” added Sudipa Sen, Country Lead, LA Singapore.
LIQVD Asia was launched in India and Singapore in February 2013. The company began with a team of 28 members across offices in Mumbai, Indore and Singapore. Some of the brands that the company works on include Adidas Originals, UCB, Sennheiser, AXIS Bank and DMTI among others.